2026 AI Tech Predictions: The Gap Between AI Experimenters Vs. Those Who Operationalize It Is Growing; Hesitant Technologists Risk Being Left Behind
FactSet Meets Demand for AI-Ready Data, First to Announce MCP Sans Intermediary
Procedureflow Announces NiCE CXone Integration to Deliver Real-Time Visual Guidance for Contact Center Agents
Exclaimer’s Latest Email Signatures for Dummies Reimagines Business Email as a Strategic Communications Channel
Nutanix Expands Capabilities to Help Customers Build and Operate Distributed Sovereign Clouds
Company to host webcast including leading DM1 expert, Dr. Charles Thornton, following presentations on May…
LONDON, April 27, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company”…
– Abstracts on 4D-150 for wet AMD/DME and 4D-310 for Fabry disease accepted for oral presentations…
BOSTON, April 27, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
– engEx™ Platform and in vitro and in vivo findings support utility across multiple therapeutic…
Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic…
WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Affinia Therapeutics, an innovative gene therapy company…
MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021…
BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…
Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO of The New…
The combined company, Palisade Bio, Inc., is expected to commence trading on the Nasdaq Capital…
BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a…
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:…
– Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta…